GIVI MPC
Alternative Names: GIVI-MPC; GIVI-MPC-IPS HEARTLatest Information Update: 26 Jul 2023
At a glance
- Originator IPS HEART
- Class Anti-inflammatories; Antineoplastics; Antirheumatics; Carbamates; Hydroxamic acids; Induced pluripotent stem cell therapies; Small molecules
- Mechanism of Action Histone deacetylase inhibitors; Tissue replacements
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Preclinical Duchenne muscular dystrophy